Stallion India Fluorochemicals Limited has announced its Board of Directors' approval for a significant rights issue worth up to ₹364.00 crores. The decision was taken during a board meeting held on Friday, January 23rd, 2026, at the company's registered office in Mumbai.

Rights Issue Structure and Details

The rights issue will comprise equity shares with a face value of ₹10.00 each, offered to eligible equity shareholders as on the record date. The board meeting, which commenced at 11:30 AM and concluded at 1:50 PM, approved the comprehensive framework for this capital raising initiative.

Rights Issue Committee Formation

The board has established a dedicated Rights Issue Committee comprising directors to oversee the entire process. This committee will have comprehensive authority to make crucial decisions regarding the rights issue implementation.

The committee's responsibilities include:

• Determination and alteration of fractional entitlements treatment
• Making necessary applications to regulatory authorities
• Finalizing terms, conditions, structure, and timing of the rights issue
• Overseeing the overall execution of the capital raising process

Key Parameters and Timeline

Several critical parameters remain to be finalized by the Rights Issue Committee and will be disclosed in the final Letter of Offer. These pending details include the specific issue price per equity share, exact number of equity shares to be offered, and the rights entitlement ratio for existing shareholders.

Regulatory Compliance and Next Steps

The announcement was made pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company will issue a detailed Letter of Offer to eligible equity shareholders holding shares as on the record date, which will specify comprehensive terms and conditions including the application procedure.

The rights issue represents a significant capital raising initiative for Stallion India Fluorochemicals, providing existing shareholders with the opportunity to participate in the company's growth plans through preferential share allocation based on their current holdings.

Stallion India Fluorochemicals Limited has announced the allotment of an industrial plot from Rajasthan State Industrial Development & Investment Corporation Limited (RIICO), marking a significant step in the company's expansion strategy. The disclosure was made in compliance with SEBI regulations on January 19, 2026.

Plot Allotment Details

The company received an allotment letter dated November 4, 2025, from RIICO for the allocation of industrial land in Rajasthan. The plot details are as follows:

Strategic Expansion Initiative

The allotment is strategically positioned to support the company's long-term expansion plans and future growth objectives. The new plot will complement the operational requirements of Stallion India's existing R-32 Manufacturing Plant, which is situated at the adjacent Plot No. SP3-10 in RIICO Industrial Area, Ukhaliya, Tehsil – Hurda, District – Bhilwara, Rajasthan.

Regulatory Compliance

The company made this disclosure pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement was signed by Govind Rao, Company Secretary & Compliance Officer, ensuring adherence to applicable regulatory provisions.

Manufacturing Operations Context

The allotment supports the company's fluorochemicals manufacturing operations, particularly its R-32 production facility. The proximity of the new plot to the existing manufacturing plant is expected to provide operational synergies and support the company's expansion in the fluorochemicals sector.